Ids and vitamin E immediately after myocardial infarction: Outcomes on the GISSI-Prevenzione
Ids and vitamin E after myocardial infarction: Results on the IL-3 Source GISSI-Prevenzione trial. Lancet 1999, 354, 44755. Marchioli, R.; Barzi, F.; Bomba, E.; Chieffo, C.; di Gregorio, D.; di Mascio, R.; Franzosi, M.G.; Geraci, E.; Levantesi, G.; Maggioni, A.P.; et al. Early protection against sudden death by n-3 polyunsaturated fatty acids immediately after myocardial infarction: Time-course analysis on the benefits on the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105, 1897903.Mar. Drugs 2013,19. Cawood, A.L.; Ding, R.; Napper, F.L.; Young, R.H.; Williams, J.A.; Ward, M.J.; Gudmundsen, O.; Vige, R.; Payne, S.P.; Ye, S.; et al. Eicosapentanoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and larger plaque EPA is related to decreased plaque inflammation and improved stability. Atherosclerosis 2010, 212, 25259. 20. British Nutrition Foundation. Unsaturated Fatty Acids: Report in the British Nutrition Foundation Process Force; Blackwell Science: Oxford, UK, 1992. 21. Mayer, K.; Merfels, M.; Muhly-Reinholz, M.; Gokorsch, S.; Rosseau, S.; Lohmeyer, J.; Schwarzer, N.; KrM.; Suttorp, N.; Grimminger, F.; et al. Omega-3 fatty acids suppress ll, monocyte adhesion to human endothelial cells: Function of endothelial PAF generation. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H811 818. 22. Mori, T.A.; Burke, V.; Puddey, I.B.; Watts, G.F.; O’Neal, D.N.; Most effective, J.D.; Beilin, L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly KDM3 Storage & Stability hyperlipidemic males. Am. J. Clin. Nutr. 2000, 71, 1085094. 23. Durrington, P.N.; Bhatnagar, D.; Mackness, M.I.; Morgan, J.; Julier, K.; Khan, M.A.; France, M. An omega-3 polyunsaturated fatty acid concentrate administered for one particular year decreased triglycerides in simvastatin treated sufferers with coronary heart illness and persisting hypertriglyceridaemia. Heart 2001, 85, 54448. 24. Harris, W.S.; Sands, S.A.; Windsor, S.L.; Ali, H.A.; Stevens, T.L.; Magalski, A.; Porter, C.B.; Borkon, A.M. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110, 1645649. 25. Hjerkinn, E.M.; Seljeflot, I.; Ellingse, I.; Berstad, P.; Hjermann, I.; Sandvik, L.; Arnesen, H. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in guys with long-standing hyperlipidemia. Am. J. Clin. Nutr. 2005, 81, 58389. 26. Eschen, O.; Christensen, J.H.; de Caterina, R.; Schmidt, E.B. Soluble adhesion molecules in healthier subjects: A dose-response study applying n-3 fatty acids. Nutr. Metab. Cardiovasc. Dis. 2004, 14, 18085. 27. Miles, E.A.; Thies, F.; Wallace, F.A.; Powell, J.R.; Hirst, T.L.; Newsholme, E.A.; Calder, P.C. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci. 2001, 100, 9100. 28. Thies, F.; Nebe-von-Caron, G.; Powell, J.R.; Yaqoob, P.; Newsholme, E.A.; Calder, P.C. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases all-natural killer cell activity in wholesome subjects aged 55 year. Am. J. Clin. Nutr. 2001, 73, 53948. 29. Balk, E.M.; Lichtenstein, A.H.; Chung, M.; Kupelnick, B.; Chew, P.; Lau, J. E.